ISR Study Finds That INC Research Delivers CRO Industry’s Most Consistent Service Quality

Informing the drug development and commercialization industry Cary, N.C. – February 28, 2012 – Industry Standard Research (ISR) today announced the availability of its 4th annual CRO Quality Benchmarking Report.  The 2012 version released Tuesday includes 125 pharmaceutical and biotechnology professionals and their experiences with dozens of small, mid-size, and large CROs offering Phase II/III … Continued

ISR Report Measures Impact of Sunshine Act on Physician, Drug Manufacturer Interactions

Informing the drug development and commercialization industry Cary, N.C. – February 26, 2012 – Industry Standard Research (ISR) today announced the release of a new pharmaceutical market research report entitled “Sunshine Act: Pharma Impact – Changes in US Physician Behavior,” which quantifies the impact the adoption of the Sunshine Act will have on physicians’ interactions … Continued

ISR CUSTOMERS